Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Alland

Showing results (61-70 of 153) with videos related to

Pageof 16
Sort By:
Journal of Clinical Microbiology|May 17, 2013
Evaluation of Xpert MTB/RIF for detection of tuberculosis from blood samples of HIV-infected adults confirms Mycobacterium tuberculosis bacteremia as an indicator of poor prognosisNicholas A Feasey, Padmapriya P Banada, William Howson, et al.
Plos Pathogens|March 7, 2019
Transmission phenotype of Mycobacterium tuberculosis strains is mechanistically linked to induction of distinct pulmonary pathologySheetal Verma, Kamlesh Bhatt, Arianne Lovey, et al.
Journal of Bacteriology|May 20, 2003
Modeling bacterial evolution with comparative-genome-based marker systems: application to Mycobacterium tuberculosis evolution and pathogenesisDavid Alland, Thomas S Whittam, Megan B Murray, et al.
The Journal of Infectious Diseases|March 14, 2015
Target product profile of a molecular drug-susceptibility test for use in microscopy centersClaudia M Denkinger, David Dolinger, Marco Schito, et al.
Journal of Clinical Microbiology|October 24, 2014
Genotypic susceptibility testing of Mycobacterium tuberculosis isolates for amikacin and kanamycin resistance by use of a rapid sloppy molecular beacon-based assay identifies more cases of low-level drug resistance than phenotypic Lowenstein-Jensen testingSoumitesh Chakravorty, Jong Seok Lee, Eun Jin Cho, et al.
Bioorganic & Medicinal Chemistry Letters|January 3, 2019
Optimization of N-benzyl-5-nitrofuran-2-carboxamide as an antitubercular agentRicardo Gallardo-Macias, Pradeep Kumar, Mark Jaskowski, et al.
Journal of Clinical Microbiology|December 10, 2020
Xpert MTB/XDR: a 10-Color Reflex Assay Suitable for Point-of-Care Settings To Detect Isoniazid, Fluoroquinolone, and Second-Line-Injectable-Drug Resistance Directly from Mycobacterium tuberculosis-Positive SputumYuan Cao, Heta Parmar, Rajiv L Gaur, et al.
Nature Communications|November 18, 2022
A comprehensive update to the Mycobacterium tuberculosis H37Rv reference genomePoonam Chitale, Alexander D Lemenze, Emily C Fogarty, et al.
BMC Infectious Diseases|August 8, 2009
Mycobacterium tuberculosis ecology in Venezuela: epidemiologic correlates of common spoligotypes and a large clonal cluster defined by MIRU-VNTR-24Edgar Abadía, Monica Sequera, Dagmarys Ortega, et al.
The Journal of Infectious Diseases|March 14, 2015
Integration of published information into a resistance-associated mutation database for Mycobacterium tuberculosisHugh Salamon, Ken D Yamaguchi, Daniela M Cirillo, et al.
Pageof 16

Showing results (61-70 of 153) with videos related to

Sort By:
Pageof 16
Journal of Clinical Microbiology|May 17, 2013
Evaluation of Xpert MTB/RIF for detection of tuberculosis from blood samples of HIV-infected adults confirms Mycobacterium tuberculosis bacteremia as an indicator of poor prognosisNicholas A Feasey, Padmapriya P Banada, William Howson, et al.
Plos Pathogens|March 7, 2019
Transmission phenotype of Mycobacterium tuberculosis strains is mechanistically linked to induction of distinct pulmonary pathologySheetal Verma, Kamlesh Bhatt, Arianne Lovey, et al.
Journal of Bacteriology|May 20, 2003
Modeling bacterial evolution with comparative-genome-based marker systems: application to Mycobacterium tuberculosis evolution and pathogenesisDavid Alland, Thomas S Whittam, Megan B Murray, et al.
The Journal of Infectious Diseases|March 14, 2015
Target product profile of a molecular drug-susceptibility test for use in microscopy centersClaudia M Denkinger, David Dolinger, Marco Schito, et al.
Journal of Clinical Microbiology|October 24, 2014
Genotypic susceptibility testing of Mycobacterium tuberculosis isolates for amikacin and kanamycin resistance by use of a rapid sloppy molecular beacon-based assay identifies more cases of low-level drug resistance than phenotypic Lowenstein-Jensen testingSoumitesh Chakravorty, Jong Seok Lee, Eun Jin Cho, et al.
Bioorganic & Medicinal Chemistry Letters|January 3, 2019
Optimization of N-benzyl-5-nitrofuran-2-carboxamide as an antitubercular agentRicardo Gallardo-Macias, Pradeep Kumar, Mark Jaskowski, et al.
Journal of Clinical Microbiology|December 10, 2020
Xpert MTB/XDR: a 10-Color Reflex Assay Suitable for Point-of-Care Settings To Detect Isoniazid, Fluoroquinolone, and Second-Line-Injectable-Drug Resistance Directly from Mycobacterium tuberculosis-Positive SputumYuan Cao, Heta Parmar, Rajiv L Gaur, et al.
Nature Communications|November 18, 2022
A comprehensive update to the Mycobacterium tuberculosis H37Rv reference genomePoonam Chitale, Alexander D Lemenze, Emily C Fogarty, et al.
BMC Infectious Diseases|August 8, 2009
Mycobacterium tuberculosis ecology in Venezuela: epidemiologic correlates of common spoligotypes and a large clonal cluster defined by MIRU-VNTR-24Edgar Abadía, Monica Sequera, Dagmarys Ortega, et al.
The Journal of Infectious Diseases|March 14, 2015
Integration of published information into a resistance-associated mutation database for Mycobacterium tuberculosisHugh Salamon, Ken D Yamaguchi, Daniela M Cirillo, et al.
Pageof 16